What is it?
Eye drops in a multi-dose bottle containing sterile solution with 2% citicoline and 0.2% high-molecular-weight hyaluronic acid.
VISNEUROX OMK1, due to the presence of Citicoline, provides a useful and conducive structural support for the repair of the integrity of damaged cell membranes and also in degenerative ophthalmic diseases, such as glaucoma.
Hyaluronic acid is obtained by biotechnological synthesis, and originates mucomimetic, mucoadhesive and viscoelastic solutions, useful for improving the stability of the tear film in order to keep the surface of the eye lubricated, hydrated and protected. Solutions based on hyaluronic acid also provide a favourable microenvironment in the repair process of the ocular surface in cases of corneal and conjunctival epithelium damage.
Indicated for
VISNEUROX OMK1, due to the presence of citicoline and its structural action on the retinal ganglion cells, is indicated as an adjuvant in the treatment of hypertension in patients with glaucoma.
In addition, the moisturising and protective properties of the product provide eye relief in the event of irritation, itching, or sensation of foreign bodies, due to environmental factors such as wind, sun, dry air, salt water, smoke, intense light, air conditioning, heating, prolonged computer use or eye surgery, conjunctivitis or the use of contact lenses.
Mode of use
1 drop, 3 times a day, as required.
Composition
Hyaluronic acid, citicoline sodium, sodium phosphate monobasic monohydrate, sodium phosphate dibasic dodecahydrate, sodium chloride, benzalkonium chloride, water for injections.
Presentation
Multi-dose bottle containing 10 ml of sterile solution.
